Professional Documents
Culture Documents
2000 - James M. Cregg-Recombinant Protein Expression in Pichia Pastoris PDF
2000 - James M. Cregg-Recombinant Protein Expression in Pichia Pastoris PDF
REVIEW
23
Abstract
The methylotrophic yeast Pichia pastoris is now one of the standard tools used in molecular biology for
the generation of recombinant protein. P. pastoris has demonstrated its most powerful success as a largescale (fermentation) recombinant protein production tool. What began more than 20 years ago as a program
to convert abundant methanol to a protein source for animal feed has been developed into what is today two
important biological tools: a model eukaryote used in cell biology research and a recombinant protein
production system. To date well over 200 heterologous proteins have been expressed in P. pastoris. Significant advances in the development of new strains and vectors, improved techniques, and the commercial
availability of these tools coupled with a better understanding of the biology of Pichia species have led to
this microbes value and power in commercial and research labs alike.
Index Entries: Pichia pastoris; Pichia methanolica; methylotrophic yeast; heterologous protein production; foreign gene expression; yeast protein expression; fermentation.
1. Introduction
the strong preference of P. pastoris for respiratory growth, a key physiological trait that
greatly facilitates its culturing at high cell densities relative to fermentative yeasts; and
a decision in 1993 by Phillips Petroleum Company continued by Research Corporation Technologies (RCT) to release the P. pastoris
expression system to academic research laboratories, the consequence of which has been an
explosion in the knowledge base of the system.
The successful expression of more than 200 different heterologous proteins in P. pastoris has
been published (Fig. 1, Table 3). A web site has
been created and is maintained by the Cregg lab
that lists heterologous proteins expressed in
Pichia pastoris (http:// www.kgi.edu/html/
noncore/program4.htm#jc).
Pichia pastoris has become a highly successful system for the expression of heterologous
genes. Several factors have contributed to its
rapid acceptance, the most important of which
include:
a promoter derived from the alcohol oxidase I
gene (AOX1) of P. pastoris that is uniquely
suited for the controlled expression of foreign
genes;
the similarity of techniques needed for the
molecular genetic manipulation of P. pastoris
to those of Saccharomyces cerevisiae, one of
the best-characterized experimental systems in
modern biology;
*Author to whom all correspondence and reprint requests should be addressed: 1Keck Graduate Institute of Applied Life Sciences, 535 North
Watson Dr. Claremont, CA 91711, Email: James_Cregg@kgi.edu. 2Oregon Graduate Institute of Science and Technology, 20,000 N.W.
Walker Rd. Beaverton, OR 97006, E-mail: jlcereg@bmb.ogi.edu. 3 Oregon Graduate Institute of Science and Technology, 20,000 N.W.
Walker Rd. Beaverton, OR 97006, Email: jshi@bmb.ogi.edu. *Idun Pharmaceuticals,11085 N. Torrey Pines Road La Jolla, CA 92037, E
mail: dhiggins@idun.com.
Molecular Biotechnology 2000 Humana Press Inc. All rights of any nature whatsoever reserved. 10736085/2000/16:1/2352/$17.50
MOLECULAR B IOTECHNOLOGY
23
24
MOLECULAR BIOTECHNOLOGY
Cregg et al.
many P. pastoris expression vectors and other
useful information can be found on the Invitrogen
web site (http://www.invitrogen.com).
2. A Brief History of the Pichia pastoris
Expression System
The ability of certain yeast species to utilize
methanol as a sole source of carbon and energy
was discovered approx 30 years ago by Koichi
Ogata (12). Because methanol could be inexpensively synthesized from natural gas (methane), there was immediate interest in exploiting
these organisms for the generation of yeast biomass or single-cell protein (SCP) to be marketed primarily as high-protein animal feed.
During the 1970s, Phillips Petroleum Company
(Bartlesville, OK) developed media and methods for growing P. pastoris on methanol in
continuous culture at high cell densities (>130
g/L dry cell weight) (13). However, during
this same period, the cost of methane
increased dramatically due to the oil crisis,
and the cost of soy beans (the major alternative source of animal feed protein) decreased.
As a result, the SCP process was never economically competitive.
In the early 1980s, Phillips Petroleum Company contracted with the Salk Institute Biotechnology/Industrial Associates, Inc. (SIBIA), a
biotechnology company located in La Jolla,
CA, to develop P. pastoris as a heterologous
gene expression system. Researchers at SIBIA
isolated the AOX1 gene (and its promoter) and
developed vectors, strains, and methods for
molecular genetic manipulation of P. pastoris
(1419). The combination of strong regulated
expression under control of the AOX1 promoter, along with the fermentation media and
methods developed for the SCP process,
resulted in strikingly high levels of foreign proteins in P. pastoris. In 1993, Phillips Petroleum
sold its patent position with the P. pastoris
expression system to RCT, the current patent
holder. In addition, Phillips Petroleum licensed
Invitrogen to sell components of the system to
researchers worldwide, an arrangement that
continues under RCT.
MOLECULAR B IOTECHNOLOGY
25
derepressing conditions (e.g., the absence of a
repressing carbon source such as glucose in the
medium) do not result in substantial transcription
of the AOX1 gene. The presence of methanol
appears to be essential to induce high levels of
transcription (16).
26
Cregg et al.
Table 1
P. pastoris Expression Host Strains
Strain
Name
Y-11430
GS115
KM71
MC100-3
SMD1168
SMD1165
SMD1163
Genotype
his4
aox1::SARG4 his4 arg4
aox1::SARG4 aox2::Phis4
his4 arg4
pep4 his4
prb1 his4
pep4 prb1 his4
Phenotype
Wild type
Mut+ His
Muts His
Mut His
Mut+ His, protease-deficient
Mut+ His, protease-deficient
Mut+ His, protease-deficient
Reference
NRRL*
15
16
18
10,11
10,11
10,11
better producers of a foreign protein than wildtype strains (21,23,24). These strains also require
much less methanol to induce expression, which
can be useful in large fermentor cultures where a
large amount of methanol is sometimes considered a significant fire hazard. However, the most
commonly used expression host is GS115 (his4),
which is wild-type with regard to the AOX1 and
AOX2 genes and grows on methanol at the wildtype rate (methanol utilization plus [Mut+] phenotype). KM71 (his4 arg4 aox1::ARG4) is a
strain in which the chromosomal AOX1 gene is
largely deleted and replaced with the S. cerevisiae
ARG4 gene (17). As a result, this strain must rely
on the much weaker AOX2 gene for AOX and
grows on methanol at a slow rate [methanol utilization slow (Muts) phenotype]. With many P.
pastoris expression vectors, it is possible to insert
an expression cassette and simultaneously delete
the AOX1 gene of a Mut+ strain (10,11,25). The
third host MC100-3 (his4 arg4 aox1::SARG4
aox2::Phis4) is deleted for both AOX genes and
is totally unable to grow on methanol (methanol
utilization minus [Mut] phenotype) (10,11,28,26).
Some secreted foreign proteins are unstable in
the P. pastoris culture medium in which they are
rapidly degraded by proteases. Major vacuolar
proteases appear to be a significant factor in degradation, particularly in fermentor cultures, owing
to the high cell density environment in combination with the lysis of a small percentage of cells.
The use of host strains that are defective in these
proteases has proven to help reduce degradation
MOLECULAR BIOTECHNOLOGY
6. Expression Vectors
Plasmid vectors designed for heterologous protein expression in P. pastoris have several common features (Table 2). The foreign gene
expression cassette is one of those and is composed
of DNA sequences containing the P. pastoris
AOX1 promoter, followed by one or more unique
restriction sites for insertion of the foreign gene,
followed by the transcriptional termination
sequence from the P. pastoris AOX1 gene that
directs efficient 3' processing and polyadenylation
of the mRNAs. Many of these vectors also include
the P. pastoris HIS4 gene as a selectable marker
Volume 16, 2000
Table 2
Common P. pastoris Expression Vectors
Selectable
markers
Features
Targeting
pHIL-D2
Intracellular
HIS4
pAO815
Intracellular
HIS4
pPIC3K
Intracellular
pPICZ
Intracellular
bler
pHWO10
Intracellular
HIS4
pGAPZ
Intracellular
bler
pHIL-S1
Secreted
HIS4
pPIC9K
Secreted
pPICZ
Secreted
bler
pGAPZ
Secreted
bler
MOLECULAR B IOTECHNOLOGY
27
References
Sreekrishna,
personal comm.
2
10
29
Invitrogen,
Carlsbad, CA
Sreekrishna,
personal comm;
Invitrogen,
Carlsbad, CA
32
10
Invitrogen,
Carlsbad, CA
28
for transformation into his4 mutant hosts of P.
pastoris, as well as sequences required for plasmid
replication and maintenance in bacteria (i.e., ColE1
replication origin and ampicillin-resistance gene).
Some vectors also contain AOX1 3' flanking
sequences that are derived from a region of the P.
pastoris genome that lies immediately 3' of the
AOX1 gene and can be used to direct fragments
containing a foreign gene expression cassette to
integration at the AOX1 locus by gene replacement
or gene insertion 3' to AOX1 gene (10,11).
Additional features that are present in certain
P. pastoris expression 2vectors serve as tools for
specialized functions. For secretion of foreign
proteins, vectors have been constructed that contain a DNA sequence immediately following the
AOX1 promoter that encodes a secretion signal.
The most frequently used of these is the S.
cerevisiae -factor prepro signal sequence
(10,11,27,28). However, vectors containing the
signal sequence derived from the P. pastoris acid
phosphatase gene (PHO1) are also available.
Vectors with dominant drug-resistance markers that allow for enrichment of strains that
receive multiple copies of foreign gene expression cassettes during transformations have been
developed. One set of vectors (pPIC3K and
pPIC9K) contains the bacterial kanamycin-resistance gene and confers resistance to high levels
of G418 upon strains that contain multiple copies of these vectors (10,11,28). Another set of
vectors (the pPICZ series) contains the Sh ble
gene from Streptoalloteichus hindustanus
(10,11). This gene is small (375 bp) and confers
resistance to the drug Zeocin in E. coli, yeasts
(including P. pastoris), and other eukaryotes.
Because the ble gene serves as the selectable
marker for both E. coli and P. pastoris, the
ZeoR vectors are much smaller (approx 3 kb)
and easier to manipulate than other P. pastoris
expression vectors. These vectors also contain
a multiple cloning site (MCS) with several
unique restriction sites for convenience of foreign gene insertion and sequences encoding the
His6 and myc epitopes so that foreign proteins
can be easily epitope-tagged at their carboxyl
termini, if desired.
MOLECULAR BIOTECHNOLOGY
Cregg et al.
Another feature present on certain vectors (e.g.,
pAO815 and the pPICZ vector series) is designed
to facilitate the construction of expression vectors
with multiple expression cassette copies (10).
Multiple copies of an expression cassette are
introduced in these vectors by inserting an expression cassette bounded by a BamHI and a BglII site
into the BamHI site of a vector already containing
a single expression cassette copy. The resulting
BamHI/BglII junction between the two cassettes
can no longer be cleaved by either enzyme allowing for the insertion of another BamHIBglIIbounded cassette into the same vector to generate
a vector with three cassette copies. The process of
addition is repeated until 68 copies of a cassette
are present in a single final vector, which is then
transformed into the P. pastoris host strain.
Recently, vectors containing alternative promoters have become available (Table 2). Unlike
the AOX1 promoter, these promoters do not
require induction by methanol, which may be
problematic in some instances. One is a strong
constitutive promoter derived from the P. pastoris
glyceraldehyde-3-phosphate dehydrogenase gene
(GAP) (29). In addition to not involving methanol, the GAP promoter is convenient since cultures do not need to be shifted from one carbon
source to another to induce expression of a foreign gene. However, this promoter is not suitable
for the expression foreign genes whose products
are toxic to P. pastoris since the constant highlevel expression can result in the selection of
nonexpressing derivative strains that have either
lost the expression vector or have gained mutations that reduce or eliminate expression of the
foreign gene.
The second promoter is from the P. pastoris
formaldehyde dehydrogenase gene (FLD1) (30).
FLD1 is required for growth of P. pastoris on either methanol as a sole carbon source or certain
methylated amines such as methylamine as a sole
nitrogen source and is strongly induced by either
of these conditions. As a result, expression of a
foreign gene placed under control of the FLD1
promoter is repressed in media containing glucose
and ammonium ions but can be independently
induced using media containing either methanol
Volume 16, 2000
7. Integration of Vectors
into the Pichia pastoris Genome
As in S. cerevisiae, linear vector DNAs can
generate stable transformants of P. pastoris via
homologous recombination between sequences
shared by the vector and host genome
(10,11,15,25). Such integrants show strong stability in the absence of selective pressure even when
present as multiple copies. All P. pastoris expression vectors carry at least one P. pastoris DNA
segment (the promoter fragment) with unique
restriction sites that can be cleaved and used to
direct the vector to integrate into the host genome
by a single crossover type insertion event. Vectors containing the P. pastoris HIS4 gene can also
be directed to integrate into the P. pastoris
genomic his4 locus.
Expression vectors that contain 3' AOX1
sequences can be integrated into the P. pastoris
genome by a single crossover event at either
AOX1 or HIS4 loci or by a gene replacement (
insertion) event at AOX1. The latter event arises
from crossovers at both the AOX1 promoter and
3' AOX1 regions of the vector and genome, and
results in the deletion of the AOX1 coding region
(i.e., gene replacement). Transformants resulting
from such an AOX1 replacement event are phenotypically His+ and Muts. Muts strains sometimes
express higher levels of foreign protein (10). In
addition, a Muts phenotype serves as a convenient
indicator to confirm the presence of an integrated
expression cassette in the P. pastoris genome.
With either single crossover or gene replacement integration strategies and selection for His+
transformants, a significant percentage of
transformants will not contain the expression vector. This appears to be due to gene conversion
events between the HIS4 gene on the vector and
the P. pastoris his4 locus such that the wild-type
HIS4 gene recombines into the genome without
MOLECULAR B IOTECHNOLOGY
29
any additional vector sequences. These events
account for 1050% of His+ transformant colonies and appear to occur at highest frequency
when using electroporation to introduce vector
DNAs.
Multiple gene insertion events at a single locus
occur spontaneously at a low but detectable frequencybetween 1 and 10% of His+ transformants (10,11,31,32). Multicopy events can occur
as gene insertions either at the AOX1 or his4 loci
and can be detected by DNA analysis methods
(e.g., PCR, Southern/dot blotting, or differential
hybridization) (3234) or by methods that directly
examine levels of the foreign protein (e.g., activity
assay, SDS-PAGE, or colony immunoblotting)
(31,32,35). It is possible to enrich transformant
populations for ones that have multiple copies of
an expression vector by use of either a G418R
or ZeoR gene-containing vector and selecting
for hyper-resistance to the appropriate drug
(10,11,28,32). It is important to note that, with the
G418R vectors, it is essential to first select for
His+ transformants and to then screen for ones that
are resistant to G418R (32). With ZeoR vectors, it
is possible to directly select for hyper-Zeo-resistant transformants (10). Drug-resistant strains resulting from either the G418R or ZeoR selection
methods can contain between one and five copies
of the expression vector. To find strains with 20
or more copies, it is usually necessary to screen
more than 100 drug-resistant strains.
8. Posttranslational Modifications
P. pastoris has the potential to perform many
of the posttranslational modifications typically
associated with higher eukaryotes. These include
processing of signal sequences (both pre- and
prepro-type), folding, disulfide bridge formation
(10,11,36), and O- and N-linked glycosylation.
Glycosylation of secreted foreign (higher)
eukaryotic proteins by P. pastoris and other fungi
can be problematic. In mammals, O-linked oligosaccharides are composed of a variety of sugars including N-acetylgalactosamine, galactose,
and sialic acid. In contrast, lower eukaryotes,
including P. pastoris, add O-oligosaccharides
solely composed of mannose (Man) residues
Volume 16, 2000
30
(4,10,11). The number of Man residues per chain,
their manner of linkage, and the frequency and
specificity of O-glycosylation in P. pastoris have
yet to be determined. One should not assume that,
because a protein is not O-glycosylated by its
native host, P. pastoris will not glycosylate it. P.
pastoris added O-linked mannose to approx 15%
of human IGF-1 protein, although this protein is
not glycosylated at all in humans. Furthermore,
one should not assume that the specific Ser and
Thr residue(s) selected for O-glycosylation by P.
pastoris will be the same as the native host.
N-glycosylation in P. pastoris and other fungi is
also different than in higher eukaryotes (4,10,11). In
all eukaryotes, it begins in the endoplasmic reticulum
with the transfer of a lipid-linked oligosaccharide unit
(Glc3Man9GlcNAc2 (Glc = glucose; GlcNAc = Nacetylglucosamine) to asparagine at the recognition
sequence Asn-X-Ser/Thr. This oligosaccharide core
unit is subsequently trimmed to Man8GlcNAc2. It is
at this point that lower and higher eukaryotic
glycosylation patterns begin to differ. The mammalian Golgi apparatus performs a series of trimming and addition reactions that generates
oligosaccharides composed of either Man5
6GlcNAc2 (high-mannose type), a mixture of several different sugars (complex type), or a
combination of both (hybrid type). Two distinct
patterns of N-glycosylation have been observed
on foreign proteins secreted by P. pastoris. Some
proteins, such as S. cerevisiae invertase, are secreted with carbohydrate structures similar in size
and structure to the core unit (Man811GlcNAc2)
(26,36).
Other foreign proteins secreted from P.
pastoris receive much more carbohydrate and appear by SDS-PAGE and Western blotting to be
hyperglycosylated (10,11,23). Interestingly, P.
pastoris does not appear to be capable of adding
1,3-terminal mannose to oligosaccharides (R.
Trimble, personal communication). This contrasts
with S. cerevisiae oligosaccharides where 1,3linked terminal mannose is common. Aside from
the probable absence of 1,3-linked mannose, little
is known regarding the structure of P. pastoris
outer-chain oligosaccharides. Furthermore, it is
also not clear why outer chains are added to some
MOLECULAR BIOTECHNOLOGY
Cregg et al.
P. pastoris-secreted proteins and not others, nor
how outer chain addition may be prevented.
N-linked high-mannose oligosaccharides
added to proteins by yeasts represent a significant
problem in the use of foreign-secreted proteins by
the pharmaceutical industry. They can be exceedingly antigenic when introduced intravenously
into mammals and are rapidly cleared from the
blood by the liver. An additional problem caused
by the differences between yeast and mammalian
N-linked glycosylation patterns is that the long
outer chains can potentially interfere with the
folding or function of a foreign protein.
31
Table 3
Heterologous Proteins Expressed in Pichia.pastoris
Protein
Comments
Mode, amount, signal sequence
References
Bacteria
Bacillus licheniformis -amylase
Bacillus stearothermophilus
D -alanine carboxypeptidase
Bordetella pertussis pertussis pertactin (P69)
Clostridium botulinum neurotoxin
(BoNT) serotype A and B
Clostridium botulinum neurotoxin
heavy chain fragment, serotype B
Clostridium botulinum neurotoxin
serotype A binding domain
Clostridium tetani tetanus toxin fragment C
Escherichia coli acid
phosphatase/phytase (appA2)
Escherichia coli -galactosidase
Escherichia coli -lactamase
Leishmania major cathepsin B-like protease
Staphylococcus aureus staphylokinase
Streptococcus equisimili streptokinase
Streptomyces subtilisin inhibitor
Streptomyces viridosporus T7A
peroxidase, endoglucanase
Toxoplasma gondii SAG1 antigen
Vibrio cholerae accessory
cholera enterotoxin (Acc)
53, 54
55
I, 3 g/L
I, 78 mg/L
34
56
I, 390 g/g
57
I, 2.4 mg total
58
I, 12 g/L
S, 28.9 U/mg
33
59
16
29
60
61
62
63
64
S, 12 mg/L, -MF
S, 7 mg/L, -MF
65
66
S, -MF
S, 400 mg/L, native
S, 400 mg/L, PHO1
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
23
82
82
Fungi
Alternaria Alt 1 allergen
Aspergillus awamori glucoamylase
Aspergillus awamori glucoamylase
catalytic domain
Aspergillus fumigatus catalase L
Aspergillus fumigatus dipeptidyl
peptidase IV (DPP IV)
Aspergillus fumigatus dipeptidyl
peptidase V (DPP V)
Aspergillus giganteus -sarcin ribotoxin
Aspergillus niger phytase (phyA)
Candida guilliermondii xylose reductase gene (xylI)
Candida rugosa lipase 1 (CRL)
Fusarium solani pectate lyase (pelC)
Fusarium solani pectate lyase (pelD)
Geotrichum candidum lipases isoenzymes
Phytophthora cryptogea -cyptogein
Rhizopus oryzae lipase
Saccharomyces cerevisiae invertase
Saccharomyces cerevisiae Ktr1p
Saccharomyces cerevisiae
MOLECULAR B IOTECHNOLOGY
32
(-1,2-mannosyltransferase)
Schizophyllum commune vitamin B2aldehyde-forming enzyme
Trametes versicolor (white rot fungus)
laccase (lccI)
Trichoderma harzianum -(1-6)-glucanase
Cregg et al.
83
84
S, 9.3 mg/L
85
I
I
86
87
S, 24 mg/L, -MF
40
S, 50 mg/L, PHO1
88
I, 400 g/g
89
90
I, 2.167 U/g
I, 18 g/g
91
92, 93
S, -MF
94
S, 50 mg/L, native
S, 1 mg/L, native
S, -MF
S, 400 mg/L, -MF
S, 1 mg/L, native
S, 1.5 g/L, PHO1
S, PHA-E
I, 22 g/L
S, 10 mg/L, -MF
S, native
I, 30 g/g
I, 20 g/g
S, 60 mg/L, -MF
S, -MF
S, native
S, 50 mg/L, -MF
95
95
96
97
98
99, 100
101
102
103, 104
105
106, 107
108
109
110
110
111
S, native
101
S, -MF
I, 25 g/g
S, 1 mg/L, -MF
S, 10 mg/L, -MF
I, 250 U/g
I, 0.5 mg/g
S, PHO1
S, -MF
S, PHO1
112
113
114
115
116, 117
118
119
120
121
122
Protists
Chondrus crispus red alga hexose oxidase
Gracilariopsis lemaneiformis red alga
-1,4-glucan lyase (GLq1)
Plasmodium falciparum merozoite
surface protein 1 (MSP-1)
Plasmodium vivax apical
Membrane antigen I (AMA-1)
Reticulomyxa filosa (giant freshwater amoeba)
2, 2 tubulin isoforms
Trypanosoma cruzi acid -mannosidase
Plants
Allium sativum (garlic) alliin lyase
Arabidopsis thaliana
NADH:nitrate reductase
Barley (Hordeum vulgare) sucrose
fructan 6-fructosyl transferase
Barley -amylase 1
Barley -amylase 2
Barley aleurone tissue -glucosidase
Coffee bean -galactosidase
Cynara cardunculus (cardoon) cyprosin
Cynodon dactylon (Bermuda grass) Cyn d 1
Galanthus nivalis agglutinin
Hevea brasiliensis hydroxynitrile lyase
Hevea brasiliensis Hev b 7 patatin-like allergen
Maize cytokinin oxidase
Oat phytochrome A, phA
Oat phytochrome A, phyA65 apoprotein
Olea europaea (olive tree) aeroallergen Ole e 1
Pepper endo--1,4-glucanase cCel1
Pepper endo--1,4-glucanase cCel2
Persea americana (avocado)
prs a 1 major allergen
Phaseolus vulgaris agglutinin
(phytohaemagglutinin)
Phleum pratense -expansin
Potato phytochrome B
Ragweed allergen Amb a 6
Soybean root nodule acid phosphatase
Spinach glycolate oxidase
Spinach phosphoribulokinase
Sugar beet defensin AX2
Timothy grass group I allergen
Tomato Lycopesicon esculentum Mill.
LeMir (L. esculentum miraculin)
Wheat lipid transfer protein
MOLECULAR BIOTECHNOLOGY
33
Invertebrates
Achacina fulica Ferussac
(giant African snail) achacin
Aplysia californica (marine invertebrate)
ADP ribosyl cyclase
Aqueora victoria (jellyfish)
green fluorescent protein
Boophilus microplus (cattle tick) Bm86
Cockroach allergen, Bla g 4
Drosophila melanogaster
angiotensin I-converting enzyme
Drosophila melanogaster
caritine palmitoyltransferase
Firefly luciferase
GAVAC vaccine against cattle tick
Haementeria ghilanii
(South American leech) ghilanten
Hirudo medicinalis (leech) hirudin
Honeybee odorant-binding protein (ASP2)
Honeybee olfactory protein
Nippostrongylus brasiliensis
(parasitic nematode) nonneuronal secreted
acetylcholine sterase
Spider dragline silk protein
Tick anticoagulant peptide
Yellowjacket venom allergen, Ag5
123
124
I, S, PHA-E
101,125
126129
130
131
I (mitochondria)
132
I (peroxisome)
S, 2.0 g/L
S, 10 mg/L, -MF
133
134
135
136
137
138
139
S, 27 mg/L, -MF
I, 663 mg/L
S, 1.7 g/L
S, 100 mg/L, -MF
140
27
141
142
143
144
145
146
147
148
4244
149
150
151
152
153
154
S, 20 mg/L, -MF
S, mg amounts, native
S*, 40 pmol/mg, -MF
S, 450 mg/L, -MF
S, 14.8 g/l, -MF
S, 10 mg/L, -MF
S, native
S, 270 mg/L, native
I (membrane-bound), 6 g/mg
S, 250 mg/L, a-MF, PHO1
45
155
156
28
157
158
159
160
161163
164
Vertebrates (nonhuman)
Bovine enterokinase catalytic domain
Bovine follicle-stimulating hormone -subunit
Bovine IFN- 1
Bovine lysozyme c2
Bovine opsin
Bovine pancreatic trypsin inhibitor (aprotinin)
Bovine -casein
Bovine -lactoglobulin
Bovine tissue-type plasminogen activator (tPA)
Bovine transcobalamin
Brushtail possum TNF
Bungarus fasciatus (snake) venom
gland acetylcholinesterase
Chicken liver -N-acetylgalactosaminidase
Electrophorus electricus
acetylcholinesterase AChE type T
Hen lysozyme
Mammalian lipocalin allergen Bos d2
Mouse 5HT5A 5-tryptamine receptor
Mouse epidermal growth factor
Mouse gelatin
Mouse gelatinase B
Mouse lysosomal acid -mannosidase
Mouse major urinary protein complex (MUP)
Mouse Mdr3 P-glycoprotein
Mouse single-chain Fv fragments (sFv)
MOLECULAR B IOTECHNOLOGY
34
Murine endostatin
Murine Golgi mannosidase IA
Murine macrophage
inflammatory protein-2 (MIP-2)
Ovine follicle-stimulating hormone (oFSH)
Porcine carboxypeptidase B
Porcine follicle-stimulating hormone
Porcine inhibitor of carbonic
anhydrase (transferrin family)
Porcine leukocyte 12-lipoxygenase
Rabbit intestinal peptide transporter (PEPT1)
Rabbit intestinal peptide transporter (PEPT2)
Rabbit monoclonal single-chain Fv specific for
recombinant human leukemia inhibitory factor
Rabbit plasma cholesteryl ester transfer protein
Rabbit testicular angiotensin-converting enzyme
Rat acetycholinesterase
Rat brain acetylcholinesterase T subunit
Rat complement regulator, crry
Rat Golgi sialoglycoprotein MG160
Rat high-mobility group 1 (HMG 1)
Rat liver mitochondrial carnitine palmitoyl
transferases I and II (CPTI and II)
Rat neural cell adhesion molecule
Rat NO synthase reductase domain
Rat peroxisomal multifunctional
enzyme (perMFE-II)
Rat procathepsin B
Sea raven type II antifreeze protein (SRAFP)
Shark 17-hydroxylase/C17,20-lyase
Syrian golden hamster prion protein PrPc
Cregg et al.
S, 200 mg/L, -MF
S, PHO1
S, 40 mg/L, -MF
165
166
167
S, 22 mg/L, -MF
S, 200 mg/L, -MF
S, 10 mg/L, PHO1
S, 5 mg/L, -MF
168
169
170
171
I
I
I
S, 100 mg/L, -MF
172
173
174
175
S, PHO1
S, PHO1, native
S, 1 mg/L, native
S, 100 U/L -MF
S, -MF
S, 10 mg/L, -MF
S, 50 mg/L, -MF
I (mitochondria)
176
177
152
178
179
180
181
182,183
S, -MF
I, 25 mg/L
I
184
185
186
187,188
37,189
190
191
S, 30 mg/L, -MF
S, -MF
S, 11.6 mg/L, -MF
S, inulinase signal sequence
I
S*, 25 nmol/g, -MF
S*, a-MF
I, 1 mg/L
126
192
193
194
195
156
196
197
S, PHO1
198
199
S, 40 mg/L, -MF
S, 24 mg/L, PHO1
S, 4.5 + 1 mg/L, native
S, 300 mg/L, native, INV
S, 1 mg/L, -MF
200
201203
204
205
206
I, 0.2 mg/L
S, 20 mg/L, -MF
207,208
209
Humans
(1,3/4) Fucosyltransferase
-1,2-Mannosidase 1B w/o TM domain
-N-Acetylgalactosaminidase (-NAGAL)
1-Antitrypsin (1-AT)
2-Antiplasmin
2-Adrenergic receptor
-Opioid receptor
ADAR1, ADAR2, ds-RNA-specific
adenosine deaminases
Alzheimers disease amyloid precursor protein
, , and -secretase products
Alzheimers disease amyloid
precursor protein, 2 domains
Amyloid precursor-like protein 2 (APLP2)
Amyloid precursor protein (APP)
Amyloid precursor proteins, rAPP695, rAPP770
Bile salt-stimulated lipase
Bivalent diabody against carcinoembryonic
antigen (CEA), T-cell coreceptor CD2
c-Kit receptor kinase domain
Carcinoembryonic antigen
MOLECULAR BIOTECHNOLOGY
MOLECULAR B IOTECHNOLOGY
35
I, 1 g/g
S, 38 mg/L, -MF
S, 10 mg/L, -MF
S, -MF
S, 5 mg/L, -MF
S, 455 mg/L, -MF
S, 255 mg/L
S, 15 mg/L, -MF
S, 24 mg/L (), 3mg/L (),
16 mg/L (), -MF
S, -MF
221
I, 0.1 mg/mL
S, 6 mg/L, -MF
222
223
I, 1 mg/L
S, 20 mg/L, -MF
S, 200 mg/L, PHO1
S, 100 mg/L, -MF
S, 100 mg/L, 75 mg/L, -MF
S, 2.3 mg/L, -MF
S, -MF
S, 0.6 mg/L, native
S, 50 mg/L, -MF
S, 1 mg/L, -MF
I (mitochondria)
224
165,225
226
227
228
229
230
231
232
233
234
S, synthetic signal
S, 600 mg/L, -MF
I
S, 810 mg/L, PHO1
S, 0.35 mg/L, -MF
I, 50 mg/L
S, 1.0 g/L, -MF
235
236
237
238
239
240
S, 17 mg/L, -MF
S, 400 mg/L, PHO1
S, 83 g/L, native
S, 6.5 mg/L, -MF
S, 400 g/L, -MF
210
211,212
213,214
215
216
217
218
219
220
241
242
243
244
245,246
S, 50 mg/L, -MF
S, 100 mg/L, native or -MF
S, 1 mg/L, PHO1
S, 1001200 mg/L, -MF
247
248
249
250
251
S, 50 mg/L, PHO1
I (endoplasmic reticulum)
S, 50 mg/L, -MF
S, 20 mg/L, -MF
S, 75 ml/L, PHO1
S, 5 mg/L, -MF
S, 2 mg/L, PHO1
252
253
254
255
256
257
258
36
Cregg et al.
S, -MF
S, 17 mg/L, PHO1
S, 10% total protein, PHO1
S, 160 mg/L, -MF
S, 180 mg/L, -MF
S, 20 mg/L, -MF
S, 30 mg/L, native
I, 0.25 mg/L
S, 670 mg/L, -MF
I, 15% total protein
S
259
260
261
262
263
264
265
266
267
268
269,270
S, 50 mg/L, -MF
S, 3 g/L, native
S, 240 mg/L, -MF
S, 4 mg/L, -MF
S, 5 mg/L, pre Mucor pusillus
rennin signal
S
S, 10 mg/L, PHO1
S, 30 mg/L, -MF
S, 170 mg/L, -MF
248
24,271274
275277
278
I, 10 g/L
S, 3 mg/L, -MF
I, 15 mg/L
S, 600 IU/mL, pre Mucor
pussils rennin
31,289
290
291
292
S, 40 mg/L, PHO1
293
S, 10 mg/L, -MF
279
280
281
282,283
18,48
284287
288
Viruses
A/VICTORIA/3/75 influenza virus
neuraminidase head domain
Bovine herpes virus-1 glycoprotein D
Dengue virus type 1 structural
gene recombinant E protein
Hepatitis B virus surface antigen
Hepatitis B virus surface
antigen-HIV gp41 epitope chimera
Hepatitis E virus ORF3
Human immunodeficiency
virus type 1 (HIV-1) envelope glycoprotein,
Polyomavirus large T antigen
Reovirus 1 core protein
Reovirus 1 protein
Vaccinia virus complement control protein
S, 3 mg/ml, -MF
294, 295
S, 20 mg/L, -MF
S, PHO1, prM virus signal sequence
296, 297
298
I, 400 mg/L
25, 299
I
I
gp120 (ENV) S, 20 mg/L, -MF
300
301
302
I, 0.5 mg/L
I, 0.8 mg/L
I
S, 3 mg/L, a-MF
303
304
305
41
I = Intracellular (with subcellular location), S = Secreted, S* = Secreted to plasma membrane. Amounts are highest reported for
particular protein. Signal sequences: -MF (S. cerevisiae -mating factor); PHO1 (P. pastoris acid phosphatase); SUC2
(S. cerevisiae invertase).
MOLECULAR BIOTECHNOLOGY
37
large numbers of mutant proteins suitable for
structure/function studies. The P. pastoris yeast
expression system offers key advantages relative
to other mammalian expression systems and to
Bacculovirus. In particular, P. pastoris grows in
minimal medium that can be modified for production of 15N-labeled proteins (37-41). Even triply
labeled (15N, 13C, 2H) proteins have been produced in this way (42,43). In some cases, the
yields of labeled proteins compete favorably with
those obtained from E. coli (4446). Another advantage of the P. pastoris yeast expression system is that glycosylated proteins can be prepared
in high yields and the sugars that are attached by
P. pastoris are of a simple high mannose form
(47,48). These sugars are easily removed by
cleavage with endoglycosidase H, leaving the
core GlcNac if advantage for X-ray crystallographic analysis where a homogeneous protein
sample is required (4950). Indeed, crystallography of glycosylated proteins can be extremely difficult if the protein is produced in mammalian
cells or in Bacculovirus because of incomplete removal of the complex sugars that these organisms
attach. A comprehensive list of heterologous proteins expressed in P. pastoris can be found in
Table 3 and at www.kgi.edu/html/noncore/program 4.htm#jc.
38
mization of parameters for transformation, protein expression, and fermentation. Similar to the
situation with P. pastoris in which its use is covered by patents that are owned by RCT, patents
covering the use of P. methanolica are owned by
ZymoGenetics, Inc. of Seattle, WA. Although
use for academic research purposes is permitted,
a license is required for commercial use after an
initial one-year commercial evaluation period.
Also like P. pastoris, P. methanolica has been licensed to Invitrogen Corp., Carlsbad, CA for distribution to academic and commercial users. P.
methanolica strains, plasmids, and licensing information can be obtained from Invitrogen.
12. Summary
Based on available data, there is an approx 50
75% probability of expressing any protein of interest in P. pastoris at a reasonable level. The
biggest hurdle seems to be generating initial successthat is, expressing a specific protein at any
level. After success at this stage, there are welldefined parameters that can be manipulated to
optimize expression, and it is often at this stage
that attractive levels of expression are achieved.
Although there are relatively few examples of
expression of 10 g/L, there are many examples
of expression in the 1 g/L range, ranking the P.
pastoris expression system as one of the most productive eukaryotic expression systems available.
There are also examples of proteins that have been
successfully expressed in P. pastoris that were
completely unsuccessful in Baculovirus or S.
cerevisiae expression systems, making the P.
pastoris system an important alternative to have
available in the protein expression "toolbox." See
Table 3 for a comprehensive list of heterologous
proteins expressed in P. pastoris.
Acknowledgments
The preparation of this manuscript was supported
by Grant DK-43698 from the National Institutes of
Health and Grant ER20334 from the Department of
Energy, Office of Basic Energy Sciences (to
J.M.C.). We would like to thank Terrie Hadfield,
Oregon Graduate Institute, for expert assistance in
preparation of the manuscript, and Elizabeth
MOLECULAR BIOTECHNOLOGY
Cregg et al.
Komives, University of California, San Diego, for
information on heavy atom labeled protein.
References
1. Romanos, M. A., Scorer, C. A., and Clare, J. J. (1992)
Foreign gene expression in yeast: a review. Yeast 8,
423488.
2. Cregg, J. M., Vedvick, T. S., and Raschke, W. C.
(1993) Recent advances in the expression of foreign
genes in Pichia pastoris. Biotechnology (NY) 11,
905910.
3. Romanos, M. (1995) Advances in the use of Pichia
pastoris for highlevel expression. Curr. Opin.
Biotechnol. 6, 527533.
4. Cregg, J. M. (1999) Expression in the methylotrophic
yeast Pichia pastoris. In Gene Expression Systems:
Using Nature for the Art of Expression (Fernandez, J.
M. and Hoeffler, J. P., eds.), Academic Press, San Diego, CA, pp. 157191.
5. Cregg, J. M. and Higgins, D. R. (1995) Production of
foreign proteins in the yeast Pichia pastoris. Can. J.
Bot. 73(Suppl. 1), S981S987.
6. Sreekrishna, K., Brankamp, R. G., Kropp, K. E.,
Blankenship, D. T., Tsay, J. T., Smith, P. L.,
Wierschke, J. D., Subramaniam, A., and Birkenberger,
L. A. (1997) Strategies for optimal synthesis and secretion of heterologous proteins in the methylotrophic
yeast Pichia pastoris. Gene 190, 5562.
7. Gellissen, G. and Hollenberg, C. P. (1997) Application of yeasts in gene expression studies: a comparison of Saccharomyces cerevisiae, Hansenula
polymorpha and Kluyveromyces lactisa review.
Gene 190, 8797.
8. Higgins, D. R. (1995) Overview of protein expression in Pichia pastoris. In Current Protocols in Protein Science, Supplement 2 (Wingfield, P. T., ed.),
John Wiley and Sons, New York, pp. 5.7.15.7.16.
9. Sreekrishna, K. (1993) Strategies for optimizing
protein expression and secretion in the
methylotrophic yeast Pichia pastoris. In Industrial
Microorganisms: Basic and Applied Molecular Genetics (Baltz, R. H., Hegeman, G. D., and Skatrud,
P. L., ed.), American Society for Microbiology,
Washington, DC, pp. 119126.
10. Higgins, D. R. and Cregg, J. M. (1998) Pichia Protocols, Methods in Molecular Biology, vol. 103,
Humana Press, Totowa, NJ.
11. Cereghino, J. L. and Cregg, J. M. (2000) Heterologous protein expression in the methylotrophic yeast
Pichia pastoris. FEMS Microbiol. Rev., 24, 45-66.
12. Ogata, K., Nishikawa, H., and Ohsugi, M. (1969) A
yeast capable of utilizing methanol. Agric. Biol.
Chem. 33, 15191520.
13. Wegner, G. H. (1990) Emerging applications of the
methylotrophic yeasts. FEMS Microbiol. Rev. 7,
279283.
MOLECULAR B IOTECHNOLOGY
39
26. Chirulova, V., Cregg, J. M., and Meagher, M. M.
(1997) Recombinant protein production in an alcohol
oxidase-defective strain of Pichia pastoris in fedbatch fermentations. Enzyme Microb. Technol. 21,
277283.
27. Laroche, Y., Storme, V., De Muetter, J., Messens,
J., and Lauwereys, M. (1994) High-level secretion
and very efficient isotopic labeling of tick anticoagulant peptide (TAP) expressed in the
methylotrophic yeast Pichia pastoris. Biotechnology
(NY) 12, 11191124.
28. Clare, J. J., Romanos, M. A., Rayment, F. B.,
Rowedder, J. E., Smith, M. A., Payne, M. M.,
Sreekrishna, K., and Henwood, C. A. (1991) Production of mouse epidermal growth factor in yeast: highlevel secretion using Pichia pastoris strains
containing multiple gene copies. Gene 105, 205212.
29. Waterham, H. R., Digan, M. E., Koutz, P. J., Lair, S.
V., and Cregg, J. M. (1997) Isolation of the Pichia
pastoris glyceraldehyde-3-phosphate dehydrogenase
gene and regulation and use of its promoter. Gene
186, 3744.
30. Shen, S., Sulter, G., Jeffries, T. W., and Cregg, J. M.
(1998) A strong nitrogen source-regulated promoter
for controlled expression of foreign genes in the yeast
Pichia pastoris. Gene 216, 93102.
31. Sreekrishna, K., Nelles, L., Potenz, R., Cruze, J.,
Mazzaferro, P., Fish, W., Fuke, M., Holden, K.,
Phelps, D., Wood, P., and Parker, K. (1989) Highlevel expression, purification, and characterization of
recombinant human tumor necrosis factor synthesized in the methylotrophic yeast Pichia pastoris.
Biochemistry 28, 41174125.
32. Scorer, C. A., Clare, J. J., McCombie, W. R., Romanos,
M. A., and Sreekrishna, K. (1994) Rapid selection using G418 of high copy number transformants of Pichia
pastoris for high-level foreign gene expression. Biotechnology (NY) 12, 181184.
33. Clare, J. J., Rayment, F. B., Ballantine, S. P.,
Sreekrishna, K., and Romanos, M. A. (1991) Highlevel expression of tetanus toxin fragment C in Pichia
pastoris strains containing multiple tandem integrations of the gene. Biotechnology (NY) 9, 455460.
34. Romanos, M. A., Clare, J. J., Beesley, K. M.,
Rayment, F. B., Ballantine, S. P., Makoff, A. J.,
Dougan, G., Fairweather, N. F., and Charles, I. G.
(1991) Recombinant Bordetella pertussis pertactin
(P69) from the yeast Pichia pastoris: high-level production and immunological properties. Vaccine 9,
901906.
35. Wung, J. L. and Gascoigne, N. R. (1996) Antibody
screening for secreted proteins expressed in Pichia
pastoris. Biotechniques 21, 808, 810, 812.
36. Trimble, R. B., Atkinson, P. H., Tschopp, J. F.,
Townsend, R. R., and Maley, F. (1991) Structure of
oligosaccharides on Saccharomyces SUC2 invertase
40
37.
38.
39.
40.
41.
42.
43.
44.
45.
46.
Cregg et al.
secreted by the methylotrophic yeast Pichia pastoris.
J. Biol. Chem. 266, 2280722817.
Gronwald, W., Loewen, M. C., Lix, B., Daugulis,
A. J., Sonnichsen, F. D., Davies, P. L. and Sykes,
B. D. (1998) The solution structure of type II antifreeze protein reveals a new member of the lectin family. Biochemistry 37, 47124721.
Kirkitadze, M. D., Krych, M., Uhrin, D., Dryden,
D. T., Smith, B. O., Cooper, A., Wang, X.,
Hauhart, R., Atkinson, J. P., and Barlow, P. N.
(1999) Independently melting modules and highly
structured intermodular junctions within complement receptor type 1. Biochemistry 38, 7019
7031.
McAlister, M. S., Brown, M. H., Willis, A. C., Rudd,
P. M., Harvey, D. J., Aplin, R., Shotton, D. M., Dwek,
R. A., Barclay, A. N., and Driscoll, P. C. (1998)
Structural analysis of the CD5 antigenexpression,
disulphide
bond
analysis
and
physical
characterisation of the CD5 scavenger receptor superfamily domain 1. Eur. J. Biochem. 257, 131141.
Morgan, W. D., Birdsall, B., Frenkiel, T. A.,
Gradwell, M. G., Burghaus, P. A., Syed, S. E.,
Uthaipibull, C., Holder, A. A., and Feeney, J. (1999)
Solution structure of an EGF module pair from the
Plasmodium falciparum merozoite surface protein 1.
J. Mol. Biol. 289, 113122.
Wiles, A. P., Shaw, G., Bright, J., Perczel, A.,
Campbell, I. D., and Barlow, P. N. (1997) NMR studies of a viral protein that mimics the regulators of
complement activation. J. Mol. Biol. 272, 253265.
Denton, H., Smith, M., Husi, H., Uhrin, D., Barlow,
P. N., Batt, C. A., and Sawyer, L. (1998) Isotopically labeled bovine beta-lactoglobulin for NMR
studies expressed in Pichia pastoris. Prot. Exp.
Purif. 14, 97103.
Uhrinova, S., Uhrin, D., Denton, H., Smith, M., Sawyer, L., and Barlow, P. N. (1998) Complete assignment of 1H, 13C and 15N chemical shifts for bovine
beta-lactoglobulin: secondary structure and topology
of the native state is retained in a partially unfolded
form. J. Biomol. NMR 12, 89107.
Kim, T. R., Goto, Y., Hirota, N., Kuwata, K., Denton,
H., Wu, S. Y., Sawyer, L., and Batt, C. A. (1997)
High-level expression of bovine beta-lactoglobulin in
Pichia pastoris and characterization of its physical
properties. Protein Eng. 10, 13391345.
Mine, S., Ueda, T., Hashimoto, Y., Tanaka, Y., and
Imoto, T. (1999) High-level expression of uniformly
15N-labeled hen lysozyme in Pichia pastoris and
identification of the site in hen lysozyme where phosphate ion binds using NMR measurements. FEBS
Lett. 448, 3337.
Wood, M. J. and Komives, E. A. (1999) Production
of large quantities of isotopically labeled protein in
Pichia pastoris by fermentation. J. Biomol. NMR 13,
149159.
MOLECULAR BIOTECHNOLOGY
59.
60.
61.
62.
63.
64.
65.
66.
67.
68.
cacy of the botulinum neurotoxin type A binding domain from Pichia pastoris as a recombinant vaccine
candidate. Infect. Immun. 66, 48174822.
Rodriguez, E., Han, Y., and Lei, X. G. (1999) Cloning, sequencing, and expression of an Escherichia
coli acid phosphatase/phytase gene (appA2) isolated
from pig colon. Biochem. Biophys. Res. Commun.
257, 117123.
Chan, V. J., Selzer, P. M., McKerrow, J. H., and
Sakanari, J. A. (1999) Expression and alteration
of the S2 subsite of the Leishmania major cathepsin B-like cysteine protease. Biochem. J. 340,
113117.
Miele, R. G., Prorok, M., Costa, V. A., and
Castellino, F. J. (1999) Glycosylation of asparagine-28 of recombinant staphylokinase with highmannose-type oligosaccharides results in a protein
with highly attenuated plasminogen activator activity. J. Biol. Chem. 274, 77697776.
Hagenson, M. J., Holden, K. A., Parker, K. A.,
Wood, P. J., Cruze, J. A., Fuke, M., Hopkins, T. R.,
and Stroman, D. W. (1989) Expression of streptokinase in Pichia pastoris yeast. Enzyme Microb.
Technol. 11, 650656.
Markaryan, A., Beall, C. J., and Kolattukudy, P. E.
(1996) Inhibition of Aspergillus serine proteinase by
Streptomyces subtilisin inhibitor and high-level expression of this inhibitor in Pichia pastoris. Biochem.
Biophys. Res. Commun. 220, 372376.
Thomas, L. and Crawford, D. L. (1998) Cloning of
clustered Streptomyces viridosporus T7A lignocellulose catabolism genes encoding peroxidase and
endoglucanase and their extracellular expression in
Pichia pastoris. Can. J. Microbiol. 44, 364372.
Biemans, R., Gregoire, D., Haumont, M., Bosseloir,
A., Garcia, L., Jacquet, A., Dubeaux, C., and Bollen,
A. (1998) The conformation of purified Toxoplasma
gondii SAG1 antigen, secreted from engineered
Pichia pastoris, is adequate for serorecognition and
cell proliferation. J. Biotechnol. 66, 137146.
Trucksis, M., Conn, T. L., Fasano, A., and Kaper, J. B.
(1997) Production of Vibrio cholerae accessory cholera enterotoxin (Ace) in the yeast Pichia pastoris. Infect. Immun. 65, 49844988.
De Vouge, M. W., Thaker, A. J., Curran, I. H., Zhang,
L., Muradia, G., Rode, H., and Vijay, H. M. (1996)
Isolation and expression of a cDNA clone encoding an
Alternaria alternata Alt a 1 subunit. Int. Arch. Allergy
Immunol. 111, 385395.
Fierobe, H.-P., Mirgorodskaya, E., Frandsen, T. P.,
Roepstorff, P., and Svensson, B. (1997) Overexpression and characterization of Aspergillus
awamori wild-type and mutant glucoamylase secreted
by the methylotrophic yeast Pichia pastoris: comparison with wild-type recombinant glucoamylase produced using Saccharomyces cerevisiae and Aspergillus
niger as hosts. Protein Expr. Purif. 9, 159170.
MOLECULAR B IOTECHNOLOGY
41
69. Heimo, H., Palmu, K., and Suominen, I. (1997) Expression in Pichia pastoris and purification of Aspergillus awamori glucoamylase catalytic domain.
Protein Expr. Purif. 11, 304.
70. Calera, J. A., Paris, S., Monod, M., Hamilton, A. J.,
Debeaupuis, J. P., Diaquin, M., Lopez-Medrano, R.,
Leal, F., and Latge, J. P. (1997) Cloning and disruption of the antigenic catalase gene of Aspergillus
fumigatus. Infect. Immun. 65, 47184724.
71. Beauvais, A., Monod, M., Wyniger, J., Debeaupuis,
J. P., Grouzmann, E., Brakch, N., Svab, J.,
Hovanessian, A. G., and Latge, J. P. (1997)
Dipeptidyl-peptidase IV secreted by Aspergillus
fumigatus, a fungus pathogenic to humans. Infect.
Immun. 65, 30423047.
72. Beauvais, A., Monod, M., Debeaupuis, J. P., Diaquin,
M., Kobayashi, H., and Latge, J. P. (1997) Biochemical and antigenic characterization of a new
dipeptidyl-peptidase isolated from Aspergillus
fumigatus. J. Biol. Chem. 272, 62386244.
73. Martnez-Ruiz, A., Martnez del Pozo, A., Lacadena,
J., Mancheo, J. M., Oaderra, M., Lpez-Otin, C.,
and Gavilanes, J. G. (1998) Secretion of recombinant
pro- and mature fungal alpha-sarcin ribotoxin by the
methylotrophic yeast Pichia pastoris: the Lys-Arg
motif is required for maturation. Protein Expr. Purif.
12, 315322.
74. Han, Y. and Lei, X. G. (1999) Role of glycosylation
in the functional expression of an Aspergillus niger
phytase (phyA) in Pichia pastoris. Arch. Biochem.
Biophys. 364, 8390.
75. Handumrongkul, C., Ma, D. P., and Silva, J. L. (1998)
Cloning and expression of Candida guilliermondii
xylose reductase gene (xyl1) in Pichia pastoris. Appl.
Microbiol. Biotechnol. 49, 399404.
76. Brocca, S., Schmidt-Dannert, C., Lotti, M.,
Alberghina, L., and Schmid, R. D. (1998) Design, total synthesis, and functional overexpression of the
Candida rugosa lip1 gene coding for a major industrial lipase. Protein Sci. 7, 14151422.
77. Guo, W., Gonzalez-Candelas, L., and Kolattukudy,
P. E. (1995) Cloning of a novel constitutively expressed pectate lyase gene pelB from Fusarium
solani f. sp. pisi (Nectria haematococca, mating
type VI) and characterization of the gene product
expressed in Pichia pastoris. J. Bacteriol. 177,
70707077.
78. Guo, W., Gonzalez-Candelas, L., and Kolattukudy,
P. E. (1996) Identification of a novel pelD gene expressed uniquely in planta by Fusarium solani f. sp.
pisi (Nectria haematococca, mating type VI) and
characterization of its protein product as an endopectate lyase. Arch. Biochem. Biophys. 332, 305312.
79. Holmquist, M., Tessier, D. C., and Cygler, M. (1997)
High-level production of recombinant Geotrichum
candidum lipases in yeast Pichia pastoris. Protein
Expr. Purif. 11, 3540.
42
80. ODonohue, M. J., Boissy, G., Huet, J. C.,
Nespoulous, C., Brunie, S., and Pernollet, J. C. (1996)
Overexpression in Pichia pastoris and crystallization
of an elicitor protein secreted by the phytopathogenic
fungus, Phytophthora cryptogea. Protein Expr. Purif.
8, 254261.
81. Minning, S., Schmidt-Dannert, C., and Schmid, R. D.
(1998) Functional expression of Rhizopus oryzae lipase in Pichia pastoris: high-level production and
some properties. J. Biotechnol. 66, 147156.
82. Romero, P. A., Lussier, M., Sdicu, A. M., Bussey,
H., and Herscovics, A. (1997) Ktr1p is an alpha-1,2mannosyltransferase of Saccharomyces cerevisiae.
Comparison of the enzymic properties of soluble recombinant Ktr1p and Kre2p/Mnt1p produced in
Pichia pastoris. Biochem. J. 321, 289295.
83. Chen, H. and McCormick, D. B. (1997) Riboflavin
5'-hydroxymethyl oxidation. Molecular cloning, expression, and glycoprotein nature of the 5'-aldehyde-forming enzyme from Schizophyllum commune. J. Biol. Chem. 272, 2007720081.
84. Jonsson, L. J., Saloheimo, M., and Penttila, M. (1997)
Laccase from the white-rot fungus Trametes versicolor: cDNA cloning of lcc1 and expression in Pichia
pastoris. Curr. Genet. 32, 425430.
85. Bom, I. J., Dielbandhoesing, S. K., Harvey, K. N.,
Oomes, S. J., Klis, F. M., and Brul, S. (1998) A new
tool for studying the molecular architecture of the fungal cell wall: one-step purification of recombinant
trichoderma beta-(16)-glucanase expressed in Pichia
pastoris. Biochim. Biophys. Acta 1425, 419424.
86. Hansen, O. C. and Stougaard, P. (1997) Hexose oxidase from the red alga Chondrus crispus. Purification, molecular cloning, and expression in Pichia
pastoris. J. Biol. Chem. 272, 1158111587.
87. Bojsen, K., Yu, S., Kragh, K. M., and Marcussen, J.
(1999) A group of alpha-1,4-glucan lyases and their
genes from the red alga Gracilariopsis lemaneiformis: purification, cloning, and heterologous expression. Biochim. Biophys. Acta 1430, 396402.
88. Kocken, C. H. M., Dubbeld, M. A., Van Der Wel, A.,
Pronk, J. T., Waters, A. P., Langermans, J. A. M.,
and Thomas, A. W. (1999) High-level expression of
Plasmodium vivax apical membrane antigen 1 (AMA1) in Pichia pastoris: strong immunogenicity in
Macaca mulatta immunized with P. vivax AMA-1
and adjuvant SBAS2. Infect. Immun. 67, 4349.
89. Linder, S., Schliwa, M., and Kube-Granderath, E.
(1997) Expression of Reticulomyxa filosa tubulins in
Pichia pastoris: regulation of tubulin pools. FEBS
Lett. 417, 3337.
90. Vandersall-Nairn, A. S., Merkle, R. K., OBrien, K.,
Oeltmann, T. N., and Moremen, K. W. (1998) Cloning, expression, purification, and characterization of
the acid alpha-mannosidase from Trypanosoma cruzi.
Glycobiology 8, 11831194.
MOLECULAR BIOTECHNOLOGY
Cregg et al.
91. Weik, R., Francky, A., Striedner, G., Raspor, P.,
Bayer, K., and Mattanovich, D. (1998) Recombinant
expression of alliin lyase from garlic (Allium sativum)
in bacteria and yeasts. Planta Med. 64, 387388.
92. Su, W., Mertens, J. A., Kanamaru, K., Campbell, W.
H., and Crawford, N. M. (1997) Analysis of wild-type
and mutant plant nitrate reductase expressed in the
methylotrophic yeast Pichia pastoris. Plant Physiol.
115, 11351143.
93. Su, W., Huber, S. C., and Crawford, N. M. (1996)
Identification in vitro of a post-translational regulatory site in the hinge 1 region of Arabidopsis nitrate
reductase. Plant Cell 8, 519527.
94. Hochstrasser, U., Luscher, M., De Virgilio, C., Boler,
T., and Wiemken, A. (1998) Expression of a functional barley sucrose-fructan 6-fructosyltransferase in
the methylotrophic yeast Pichia pastoris. FEBS Lett.
440, 356360.
95. Juge, N., Andersen, J. S., Tull, D., Roepstorff, P., and
Svensson, B. (1996) Overexpression, purification,
and characterization of recombinant barley alphaamylases 1 and 2 secreted by the methylotrophic yeast
Pichia pastoris. Protein Expr. Purif. 8, 204214.
96. Tibbot, B. K., Henson, C. A., and Skadsen, R. W.
(1998) Expression of enzymatically active, recombinant barley alpha-glucosidase in yeast and immunological detection of alpha-glucosidase from seed
tissue. Plant Mol. Biol. 38, 379391.
97. Zhu, A., Monahan, C., Zhang, Z., Hurst, R., Leng, L.,
and Goldstein, J. (1995) High-level expression and
purification of coffee bean alpha-galactosidase produced in the yeast Pichia pastoris. Arch. Biochem.
Biophys. 324, 6570.
98. White, P. C., Cordeiro, M. C., Arnold, D., Brodelius,
P. E., and Kay, J. (1999) Processing, activity, and inhibition of recombinant cyprosin, an aspartic proteinase from cardoon (Cynara cardunculus). J. Biol.
Chem. 274, 1668516693.
99. Chang, Z. N., Peng, H. J., Lee, W. C., Chen, T. S.,
Chua, K. Y., Tsai, L. C., Chi, C. W., and Han, S. H.
(1999) Sequence polymorphism of the group 1 allergen of Bermuda grass pollen. Clin. Exp. Allergy 29,
488496.
100. Smith, P. M., Suphioglu, C., Griffith, I. J., Theriault,
K., Knox, R. B., and Singh, M. B. (1996) Cloning
and expression in yeast Pichia pastoris of a biologically active form of Cyn d 1, the major allergen of
Bermuda grass pollen. J. Allergy Clin. Immunol. 98,
331343.
101. Raemaekers, R. J. M., de Muro, L., Gatehouse, J. A.,
and Fordham-Skelton, A. P. (1999) Functional phytohaemagglutinin (PHA) and Galanthus nivalis agglutinin (GNA) expressed in Pichia pastoris: correct
N-terminal processing and secretion of heterologous
proteins expressed using the PHA-E signal peptide.
Eur. J. Biochem. 265, 394403.
MOLECULAR B IOTECHNOLOGY
43
113.
114.
115.
116.
117.
118.
119.
120.
121.
122.
123.
124.
44
125.
126.
127.
128.
129.
130.
131.
132.
133.
134.
Cregg et al.
Pichia pastoris by fermentation. Protein Expr.
Purif. 11, 104110.
Monosov, E. Z., Wenzel, T. J., Luers, G. H., Heyman,
J. A., and Subramani, S. (1996) Labeling of peroxisomes with green fluorescent protein in living P.
pastoris cells. J. Histochem. Cytochem. 44, 581589.
Gallet, P. F., Vaujour, H., Petit, J. M., Maftah, A.,
Oulmouden, A., Oriol, R., Le Narvor, C., Guilloton,
M., and Julien, R. (1998) Heterologous expression of
an engineered truncated form of human Lewis
fucosyltransferase (Fuc-TIII) by the methylotrophic
yeast Pichia pastoris. Glycobiology 8, 919925.
Garcia-Garcia, J. C., Soto, A., Nigro, F., Mazza, M.,
Joglar, M., Hechevarria, M., Lamberti, J., and de la
Fuente, J. (1998) Adjuvant and immunostimulating
properties of the recombinant Bm86 protein expressed in Pichia pastoris. Vaccine 16, 10531055.
Garcia-Garcia, J. C., Montero, C., Rodriquez, M.,
Soto, A., Redondo, M., Valdes, M., Mendez, L., and
de la Fuente, J. (1998) Effect of particulation on the
immunogenic and protective properties of the recombinant Bm86 antigen expressed in Pichia pastoris.
Vaccine 16, 374380.
Rodrguez, M., Rubiera, R., Penichet, M.,
Montesinos, R., Cremata, J., Falcn, V., Snchez, G.,
Bringas, R., Cordovs, C., Valds, M., Lleonart, R.,
Herrera, L., and de la Fuente, J. (1994) High level
expression of the B. microplus Bm86 antigen in the
yeast Pichia pastoris forming highly immunogenic
particles for cattle. J. Biotechnol. 33, 135146.
Vailes, L. D., Kinter, M. T., Arruda, L. K., and
Chapman, M. D. (1998) High-level expression of
cockroach allergen, Bla g 4, in Pichia pastoris. J. Allergy Clin. Immunol. 101, 274280.
Williams, T. A., Michaud, A., Houard, X., Chauvet,
M. T., Soubrier, F., and Corvol, P. (1996) Drosophila
melanogaster angiotensin I-converting enzyme expressed in Pichia pastoris resembles the C domain of
the mammalian homologue and does not require
glycosylation for secretion and enzymic activity.
Biochem. J. 318, 125131.
Jackson, V. N., Cameron, J. M., Zammit, V. A., and
Price, N. T. (1999) Sequencing and functional expression of the malonyl-CoA-sensitive carnitine
palmitoyltransferase from Drosophila melanogaster.
Biochem. J. 341, 483489.
McCollum, D., Monosov, E., and Subramani, S.
(1993) The pas8 mutant of Pichia pastoris exhibits
the peroxisomal protein import deficiencies of
Zellweger syndromethe PAS8 protein binds to the
COOH-terminal tripeptide peroxisomal targeting signal, and is a member of the TPR protein family. J.
Cell Biol. 121, 761774.
Canales, M., Enriquez, A., Ramos, E., Cabrera, D.,
Dandie, H., Soto, A., Falcon, V., Rodriguez, M., and
de la Fuente, J. (1997) Large-scale production in
MOLECULAR BIOTECHNOLOGY
135.
136.
137.
138.
139.
140.
141.
142.
143.
144.
145.
146.
147.
148.
149.
150.
151.
152.
153.
154.
155.
156.
MOLECULAR B IOTECHNOLOGY
45
157.
158.
159.
160.
161.
162.
163.
164.
165.
166.
167.
46
168.
169.
170.
171.
172.
173.
174.
175.
176.
177.
178.
Cregg et al.
sequence analysis and mutagenesis identify receptor
binding epitopes. Protein Sci. 6, 16431652.
Fidler, A. E., Lun, S., Young, W., and McNatty, K. P.
(1998) Expression and secretion of a biologically active glycoprotein hormone, ovine follicle stimulating
hormone, by Pichia pastoris. J. Mol. Endocrinol. 21,
327336.
Ventura, S., Villegas, V., Sterner, J., Larson, J.,
Vendrell, J., Hershberger, C. L., Aviles, F. X. (1999)
Mapping the pro-region of carboxypeptidase B by
protein engineering. Cloning, overexpression, and
mutagenesis of the porcine proenzyme. J. Biol. Chem.
274, 1992519933.
Richard, F., Robert, P., Remy, J. J., Martinat, N.,
Bidart, J. M., Salesse, R., and Combarnous, Y. (1998)
High-level secretion of biologically active recombinant porcine follicle-stimulating hormone by the
methylotrophic yeast Pichia pastoris. Biochem.
Biophys. Res. Commun. 245, 847852.
Wuebbens, M. W., Roush, E. D., Decastro, C. M., and
Fierke, C. A. (1997) Cloning, sequencing, and recombinant expression of the porcine inhibitor of carbonic
anhydrase: a novel member of the transferrin family.
Biochemistry 36, 43274336.
Reddy, R. G., Yoshimoto, T., Yamamoto, S., and
Marnett, L. J. (1994) Expression, purification, and
characterization of porcine leukocyte 12lipoxygenase produced in the methylotrophic yeast,
Pichia pastoris. Biochem. Biophys. Res. Commun.
205, 381388.
Doring, F., Theis, S., and Daniel, H. (1997) Expression and functional characterization of the mammalian intestinal peptide transporter PEPT1 in the
methylotrophic yeast Pichia pastoris. Biochem.
Biophys. Res. Commun. 232, 656662.
Doring, F., Michel, T., Rosel, A., Nickolaus, M., and
Daniel, H. (1998) Expression of the mammalian renal peptide transporter PEPT2 in the yeast Pichia
pastoris and applications of the yeast system for functional analysis. Mol. Membr. Biol. 15, 7988.
Ridder, R., Schmitz, R., Legay, F., and Gram, H.
(1995) Generation of rabbit monoclonal antibody
fragments from a combinatorial phage display library
and their production in the yeast Pichia pastoris. Biotechnology (NY) 13, 255260.
Kotake, H., Li, Q., Ohnishi, T., Ko, K. W.,
Agellon, L. B., and Yokoyama, S. (1996) Expression and secretion of rabbit plasma cholesteryl ester transfer protein by Pichia pastoris. J. Lipid Res.
37, 599605.
Sadhukhan, R., Sen, G. C., and Sen, I. (1996) Synthesis and cleavagesecretion of enzymatically active rabbit angiotensin-converting enzyme in Pichia
pastoris. J. Biol. Chem. 271, 1831018313.
Heim, J., Schmidt-Dannert, C., Atomi, H., and
Schmid, R. D. (1998) Functional expression of a
mammalian acetylcholinesterase in Pichia pastoris:
MOLECULAR BIOTECHNOLOGY
179.
180.
181.
182.
183.
184.
185.
186.
187.
188.
MOLECULAR B IOTECHNOLOGY
47
200. Cappai, R., Mok, S. S., Galatis, D., Tucker, D. F.,
Henry, A., Beyreuther, K., Small, D. H. and Masters,
C. L. (1999) Recombinant human amyloid precursorlike protein 2 (APLP2) expressed in the yeast Pichia
pastoris can stimulate neurite outgrowth. FEBS Lett.
442, 9598.
201. Henry, A., Masters, C. L., Beyreuther, K., and
Cappai, R. (1997) Expression of human amyloid precursor protein ectodomains in Pichia pastoris: analysis of culture conditions, purification, and
characterization. Protein Expr. Purif. 10, 283291.
202. Culvenor, J. G., Henry, A., Hartmann, T., Evin, G.,
Galatis, D., Friedhuber, A., Jayasena, U. L.,
Underwood, J. R., Beyreuther, K., Masters, C. L., and
Cappai, R. (1998) Subcellular localization of the
Alzheimers disease amyloid precursor protein and
derived polypeptides expressed in a recombinant
yeast system. Amyloid 5, 7989.
203. Markaryan, A., Morosova, I., Lee, B.-S., and Kaplan,
A. (1999) Atypical processing of amyloid precursor
fusion protein by proteolytic activity in Pichia
pastoris. Biochem. Biophys. Res. Commun. 262, 263
268.
204. Ohsawa, I., Hirose, Y., Ishiguro, M., Imai, Y., Ishiura,
S., and Kohsaka, S. (1995) Expression, purification,
and neurotrophic activity of amyloid precursor protein-secreted forms produced by yeast. Biochem.
Biophys. Res. Commun. 213, 5258.
205. Sahasrabudhe, A. V., Solapure, S. M., Khurana, R.,
Suryanarayan, V., Ravishankar, S., deSousa, S. M.,
and Das, G. (1998) Production of recombinant human bile salt stimulated lipase and its variant in
Pichia pastoris. Protein Expr. Purif. 14, 425433.
206. FitzGerald, K., Hollinger, P., and Winter, G. (1997)
Improved tumour targeting by disulphide stabilized
diabodies expressed in Pichia pastoris. Protein Eng.
10, 12211225.
207. Lam, L. P. and Berger, S. A. (1997) Intracellular expression and purification of the c-kit receptor kinase
domain in Pichia pastoris. Biotechniques 23, 8386.
208. Lam, L. P., Chow, R. Y., and Berger, S. A. (1999) A
transforming mutation enhances the activity of the cKit soluble tyrosine kinase domain. Biochem. J. 338,
131138.
209. You, Y. H., Hefta, L. J., Yazaki, P. J., Wu, A. M., and
Shively, J. E. (1998) Expression, purification, and
characterization of a two domain carcinoembryonic
antigen minigene (N-A3) in Pichia pastoris. The essential role of the N-domain. Anticancer Res. 18,
31933201.
210. Sun, J., Bottomley, S. P., Kumar, S., and Bird, P. I.
(1997) Recombinant caspase-3 expressed in Pichia
pastoris is fully activated and kinetically indistinguishable from the native enzyme. Biochem. Biophys.
Res. Commun. 238, 920924.
211. Linnevers, C. J., McGrath, M. E., Armstrong, R.,
Mistry, F. R., Barnes, M. G., Klaus, J. L., Palmer, J.
48
212.
213.
214.
215.
216.
217.
218.
219.
220.
221.
Cregg et al.
T., Katz, B. A., and Bromme, D. (1997) Expression
of human cathepsin K in Pichia pastoris and preliminary crystallographic studies of an inhibitor complex.
Protein Sci. 6, 919921.
Hou, W. S., Brommer, D., Zhao, Y., Mehler, E.,
Dushey, C., Weinstein, H., Miranda, C. S., Fraga, C.,
Greig, F., Carey, J., Rimoin, D. L., Desnick, R. J.,
and Gelb, B. D. (1999) Characterization of novel
cathepsin K mutations in the pro and mature polypeptide regions causing pycnodysostosis. J. Clin. Invest.
103, 731738.
Menard, R., Carmona, E., Takebe, S., Dufour, E.,
Plouffe, C., Mason, P., and Mort, J. S. (1998) Autocatalytic processing of recombinant human
procathepsin L. Contribution of both intermolecular
and unimolecular events in the processing of
procathepsin L in vitro. J. Biol. Chem. 273, 4478
4484.
Carmona, E., Dufour, E., Plouffe, C., Takebe, S.,
Mason, P., Mort, J. S., and Menard, R. (1996) Potency and selectivity of the cathepsin L propeptide as
an inhibitor of cysteine proteases. Biochemistry 35,
81498157.
Bromme, D., Li, Z., Barnes, M., and Mehler, E.
(1999) Human cathepsin V functional expression, tissue distribution, electrostatic surface potential, enzymatic characterization, and chromosomal
localization. Biochemistry 38, 23772385.
Ngler, D. K., Zhang, R., Tam, W., Sulea, T.,
Purisima, E. O., and Menard, R. (1999) Human cathepsin X: a cysteine protease with unique carboxypeptidase activity. Biochemistry 38, 1264812654.
Munshi, C. B., Fryxell, K. B., Lee, H. C., and
Branton, W. D. (1997) Large-scale production of human CD38 in yeast by fermentation. Methods
Enzymol. 280, 318330.
McGrew, J. T., Leiske, D., Dell, B., Klinke, R.,
Krasts, D., Wee, S. F., Abbott, N., Armitage, R., and
Harrington, K. (1997) Expression of trimeric CD40
ligand in Pichia pastoris: use of a rapid method to
detect high-level expressing transformants. Gene 187,
193200.
Gerstmayer, B., Altenschmidt, U., Hoffmann, M., and
Wels, W. (1997) Costimulation of T cell proliferation by a chimeric B7-2 antibody fusion protein specifically targeted to cells expressing the erbB2
proto-oncogene. J. Immunol. 158, 45844590.
Sen Gupta, C. and Dighe, R. R. (1999)
Hyperexpression of biologically active human chorionic gonadotropin using the methylotropic yeast
Pichia pastoris. J. Mol. Endocrinol. 22, 273283.
Daniels, G. L., Green, C. A., Powell, R. M., and
Ward, T. (1998) Hemagglutination inhibition of
Cromer blood group antibodies with soluble recombinant decay-accelerating factor. Transfusion 38,
332336.
MOLECULAR BIOTECHNOLOGY
MOLECULAR B IOTECHNOLOGY
49
244. Liao, Y. F., Lal, A., and Moremen, K. W. (1996)
Cloning, expression, purification, and characterization of the human broad specificity lysosomal acid
alpha-mannosidase. J. Biol. Chem. 271, 28348
28358.
245. Chan, H., Elrod, K. C., Numerof, R. P., Sideris, S.,
and Clark, J. M. (1999) Expression and characterization of recombinant mast cell tryptase. Protein Expr.
Purif. 15, 251257.
246. Niles, A. L., Maffitt, M., Haak-Frendscho, M.,
Wheeless, C. J., and Johnson, D. A. (1998) Recombinant human mast cell tryptase beta: stable expression
in Pichia pastoris and purification of fully active enzyme. Biotechnol. Appl. Biochem. 28, 125131.
247. Kalandadze, A., Galleno, M., Foncerrada, L.,
Strominger, J. L., and Wucherpfennig, K. W. (1996)
Expression of recombinant HLA-DR2 molecules.
Replacement of the hydrophobic transmembrane region by a leucine zipper dimerization motif allows
the assembly and secretion of soluble DR alpha-beta
heterodimers. J. Biol. Chem. 271, 2015620162.
248. Luo, D., Mah, N., Krantz, M., Wilde, K., Wishart, D.,
Zhang, Y., Jacobs, F., and Martin, L. (1995) Vllinker-Vh orientation-dependent expression of single
chain Fv-containing an engineered disulfide-stabilized bond in the framework regions. J. Biochem. (Tokyo) 118, 825831.
249. Beall, C. J., Breckenridge, S. M., Chakravarty, L., and
Kolattukudy, P. E. (1998) Expression of human
monocyte chemoattractant protein-1 in the yeast
Pichia pastoris. Protein Expr. Purif. 12, 145150.
250. Masure, S., Paemen, L., Proost, P., Van Damme, J.,
and Opdenakker, G. (1995) Expression of a human
mutant monocyte chemotactic protein 3 in Pichia
pastoris and characterization as an MCP-3 receptor
antagonist. J. Interferon Cytokine Res. 15, 955963.
251. Kroll, K. A., Otte, S., Hirschfeld, G., BarnikolWatanabe, S., Gotz, H., Sternbach, H., Kratzin, H. D.,
Barnikol, H. U., and Hilschmann, N. (1999) Heterologous overexpression of human NEFA and studies
on the two EF-hand calcium-binding sites. Biochem.
Biophys. Res. Commun. 260, 18.
252. Kiselyov, V. V., Berezin, V., Maar, T. E., Soroka, V.,
Edvardsen, K., Schousboe, A., and Bock, E. (1997)
The first immunoglobulin-like neural cell adhesion
molecule (NCAM) domain is involved in double-reciprocal interaction with the second immunoglobulin-like NCAM domain and in heparin binding. J.
Biol. Chem. 272, 1012510134.
253. Yang, Y. S., Yang, M. C., Tucker, P. W., and Capra,
J. D. (1997) NonO enhances the association of many
DNA-binding proteins to their targets. Nucleic Acids
Res. 25, 22842292.
254. Moritz, R. L., Ward, L. D., Tu, G.-F., Fabri, L. J., Ji,
H., Yasukawa, K., and Simpson, R. J. (1999) The Nterminus of gp130 is critical for the formation of the
50
255.
256.
257.
258.
259.
260.
261.
262.
263.
264.
265.
266.
267.
Cregg et al.
high-affinity interleukin-6 receptor complex. Growth
Factors 16, 265278.
Rydberg, E. H., Sidhu, G., Vo, H. C., Hewitt, J., Cote,
H. C., Wang, Y., Numao, S., MacGillivray, R. T.,
Overall, C. M., Brayer, G. D., and Withers, S. G.
(1999) Cloning, mutagenesis, and structural analysis
of human pancreatic alpha-amylase expressed in
Pichia pastoris. Protein Sci. 8, 635643.
Yang, Y. and Lowe, M.E. (1998) Human pancreatic
triglyceride lipase expressed in yeast cells: purification
and characterization. Protein Expr. Purif. 13, 3640.
Dufour, E., Tam, W., Nagler, D. K., Storer, A. C.,
and Menard, R. (1998) Synthesis of amidrazones using an engineered papain nitrile hydratase. FEBS Lett.
433, 7882.
Heimo, H., Palmu, K., and Suominen, I. (1998) Human placental alkaline phosphatase: expression in
Pichia pastoris, purification and characterization of
the enzyme. Protein Expr. Purif. 12, 8592.
Dutta, B., Mukhopadhyay, D., Roy, N., Das, G., and
Karande, A. A. (1998) Cloning, expression, purification, and immunocharacterization of placental protein-14. Protein Expr. Purif. 14, 327334.
Duman, J. G., Miele, R. G., Liang, H., Grella, D. K.,
Sim, K. L., Castellino, F. J., and Bretthauer, R. K.
(1998) O-Mannosylation of Pichia pastoris cellular
and recombinant proteins. Biotechnol. Appl.
Biochem. 28, 3945.
Sim, B. K., OReilly, M. S., Liang, H., Fortier, A. H.,
He, W., Madsen, J. W., Lapcevich, R., and Nacy, C.
A. (1997) A recombinant human angiostatin protein
inhibits experimental primary and metastatic cancer.
Cancer Res. 57, 13291334.
Nilsen S. L., Prorok, M., Castellino, F. J. (1999) Enhancement through mutagenesis of the binding of the
isolated kringle 2 domain of human plasminogen to
omega-amino acid ligands and to an internal sequence
of a Streptococcal surface protein. J. Biol. Chem. 274,
2238022386.
Reverter, D., Ventura, S., Villegas, V., Vendrell, J.,
and Aviles, F. X. (1998) Overexpression of human
procarboxypeptidase A2 in Pichia pastoris and detailed characterization of its activation pathway. J.
Biol. Chem. 273, 35353541.
Illy, C., Quraishi, O., Wang, J., Purisima, E., Vernet,
T., and Mort, J. S. (1997) Role of occluding loop in
cathepsin B activity. J. Biol. Chem. 272, 11971202.
Cordle, R. A. and Lowe, M. E. (1998) Purification
and characterization of human procolipase expressed
in yeast cells. Protein Expr. Purif. 13, 3035.
Lima, C. D., Klein, M. G., Weinstein, I. B., and
Hendrickson, W. A. (1996) Three-dimensional structure of human protein kinase C interacting protein 1,
a member of the HIT family of proteins. Proc. Natl.
Acad. Sci. U.S.A. 93, 53575362.
Harmsen, M. C., Heeringa, P., van der Geld, Y. M.,
Huitema, M. G., Klimp, A., Tiran, A., and
MOLECULAR BIOTECHNOLOGY
268.
269.
270.
271.
272.
273.
274.
275.
276.
277.
278.
MOLECULAR B IOTECHNOLOGY
51
291.
292.
293.
294.
295.
296.
297.
298.
299.
300.
301.
302.
macroglobulin receptor/low-density lipoprotein receptor-related protein and very-low-density lipoprotein receptor involves basic residues in the inhibitor.
Biochem. J. 329, 5563.
Vuorela, A., Myllyharju, J., Nissi, R., Pihlajaniemi,
T., and Kivirikko, K. I. (1997) Assembly of human
prolyl 4-hydroxylase and type III collagen in the yeast
Pichia pastoris: formation of a stable enzyme tetramer requires coexpression with collagen and assembly of a stable collagen requires coexpression
with prolyl 4-hydroxylase. EMBO J. 16, 67026712.
Okabayashi, K., Tsujikawa, M., Morita, M., Einaga,
K., Tanaka, K., Tanabe, T., Yamanouchi, K., Hirama,
M., Tait, J. F., and Fujikawa, K. (1996) Secretory production of recombinant urokinase-type plasminogen
activator-annexin V chimeras in Pichia pastoris.
Gene 177, 6976.
Mohanraj, D., Olson, T., and Ramakrishnan, S. (1995)
Expression of biologically active human vascular endothelial growth factor in yeast. Growth Factors 12, 1727.
Saelens, X., Vanlandschoot, P., Martinet, W., Maras,
M., Neirynck, S., Contreras, R., Fiers, W., and Jou,
W. M. (1999) Protection of mice against a lethal influenza virus challenge after immunization with
yeast-derived secreted influenza virus hemagglutinin.
Eur. J. Biochem. 260, 166175.
Martinet, W., Saelens, X., Deroo, T., Neirynck, S.,
Contreras, R., Min Jou, W., and Fiers, W. (1997) Protection of mice against a lethal influenza challenge
by immunization with yeast-derived recombinant influenza neuraminidase. Eur. J. Biochem. 247, 332
338.
Zhu, X., Wu, S., and Letchworth, G. J., III (1997)
Yeast-secreted bovine herpesvirus type 1 glycoprotein D has authentic conformational structure and
immunogenecity. Vaccine 15, 679688.
Zhu, X., Wu, S., and Letchworth, G. J. (1999) A chimeric protein comprised of bovine herpesvirus type 1
glycoprotein D and bovine interleukin-6 is secreted
by yeast and possesses biological activities of both
molecules. Vaccine 17, 269282.
Sugrue, R. J., Fu, J., Howe, J., and Chan, Y. C. (1997)
Expression of the dengue virus structural proteins in
Pichia pastoris leads to the generation of virus-like
particles. J. Gen. Virol. 78, 18611866.
Chiou, H. L., Lee, T. S., Kuo, J., Mau, Y. C., and Ho, M.
S. (1997) Altered antigenicity of a determinant variants of hepatitis B virus. J. Gen. Virol. 78, 26392645.
Eckart, M. R. and Bussineau, C. M. (1996) Quality
and authenticity of heterologous proteins synthesized
in yeast. Curr. Opin. Biotechnol. 7, 525530.
Lal, S. K., Tulasiram, P., and Jameel, S. (1997) Expression and characterization of the hepatitis E virus
ORF3 protein in the methylotrophic yeast, Pichia
pastoris. Gene 190, 6367.
Scorer, C. A., Buckholz, R. G., Clare, J. J., and Romanos,
M. A. (1993) The intracellular production and secretion
52
of HIV-1 envelope protein in the methylotrophic yeast Pichia pastoris. Gene 136,
111119.
303. Peng, Y. C. and Acheson, N. H. (1997) Production of active polyomavirus large T antigen in
yeast Pichia pastoris. Virus Res. 49, 4147.
304. Bisaillon, M., Bergeron, J., and Lemay, G. (1997)
Characterization of the nucleoside triphosphate
MOLECULAR BIOTECHNOLOGY
Cregg et al.